Maternal Serum Isthmin-1 as a Novel Biomarker for Late-Onset Fetal Growth Restriction

Özge Öztürk, Recep Taha Ağaoğlu, Gunel Aliyeva, Mesut Şimşek, Kadriye Yakut Yücel

Open source

DOI
10.3390/jcm15187018
Published
2026-09-10
Container
Journal of Clinical Medicine
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm15187018,
  title = {Maternal Serum Isthmin-1 as a Novel Biomarker for Late-Onset Fetal Growth Restriction},
  author = {Özge Öztürk and Recep Taha Ağaoğlu and Gunel Aliyeva and Mesut Şimşek and Kadriye Yakut Yücel},
  year = {2026},
  journal = {Journal of Clinical Medicine},
  doi = {10.3390/jcm15187018},
  url = {https://doi.org/10.3390/jcm15187018}
}

RIS

TY  - JOUR
TI  - Maternal Serum Isthmin-1 as a Novel Biomarker for Late-Onset Fetal Growth Restriction
AU  - Özge Öztürk
AU  - Recep Taha Ağaoğlu
AU  - Gunel Aliyeva
AU  - Mesut Şimşek
AU  - Kadriye Yakut Yücel
PY  - 2026
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm15187018
UR  - https://doi.org/10.3390/jcm15187018
ER  - 

APA

Öztürk, Ö., Ağaoğlu, R. T., Aliyeva, G., Şimşek, M., & Yücel, K. Y. (2026). Maternal Serum Isthmin-1 as a Novel Biomarker for Late-Onset Fetal Growth Restriction. Journal of Clinical Medicine. https://doi.org/10.3390/jcm15187018

Source records